我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

影响急性心肌梗死患者住院病死率的因素

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第2期
页码:
244
栏目:
临床研究
出版日期:
2009-03-30

文章信息/Info

Title:
Factors affecting in-hospital mortality in patients with acute myocardial infarction
作者:
蒋世亮1; 季晓平2; 王勇1; 王晓荣2; 张蕾2; 张澄2; 张运2
1.山东大学附属省立医院心内科，山东 济南 250021；2.山东大学齐鲁医院心内科，山东 济南 250012
Author(s):
JIANG Shi-liang;  JI Xiao-ping;  WANG Yong;  WANG Xiao-rong;  ZHANG Lei;  ZHANG Cheng;  ZHANG Yun
Department of Cardiology, Shandong University Affiliated Provincial Hospital, Jinan 250021, Shandong, China; Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
关键词:
心肌梗死; 急性; 影响因素; 病死率
Keywords:
myocardial infarction;  acute;  factors;  mortality
分类号:
R543.3
DOI:
-
文献标识码:
A
摘要:
目的 探讨影响急性心肌梗死（AMI）患者住院病死率的因素。方法 回顾分析AMI患者2 136例，比较出院时存活和住院期间死亡两组患者的临床特征和住院治疗，并应用Logistic回归分析筛选影响AMI患者住院病死率的因素。结果 与存活组相比，死亡组患者年龄较大［(71±10)岁 vs （62±11）岁,P<0.01］，男性和有吸烟史者较少（56.0% vs 71.5%，P<0.01；45.2% vs 54.2%，P<0.05），高血压病、糖尿病和高脂血症患病率较高（分别为58.3% vs 43.2%，47.7% vs 21.1%，72.0% vs 58.8%，均P<0.01），心功能Killip分级较高（2.0±1.1 vs 1.2±0.5，P<0.01），急性期再灌注治疗率和住院期间β受体阻滞剂及硝酸酯类药物的使用率较低（分别为10.1% vs 30.3%，47.0% vs 71.1%，95.2% vs 98.6%，均P<0.01）。Logistic回归分析显示年龄、高血压病、糖尿病、高脂血症、心功能Killip分级、再灌注治疗、β受体阻滞剂和硝酸酯类药物的使用率为影响AMI患者住院病死率的独立危险因素。结论 年龄、高血压病、糖尿病、高脂血症、心功能Killip分级、再灌注治疗、β受体阻滞剂和硝酸酯类药物的使用率对AMI患者住院病死率有显著影响。
Abstract:
AIM To investigate factors affecting in-hospital mortality in patients with acute myocardial infarction (AMI). METHODS A retrospective study was conducted in 2 136 patients with AMI, whose baseline characteristics and therapeutic approaches during hospital stay were compared between the survivors (1 968) and the dead (168). To identify the significant factors predictive of in-hospital death, multivariate logistic regression analysis was performed. RESULTS Compared with those of the survivors, the dead were substantially older ［(71±10) vs (62±11) years, P<0.01］, had a higher prevalence of hypertensive disease, diabetes mellitus and hyperlipidemia (58.3% vs 43.2%, 47.7% vs 21.1%, 72.0% vs 58.8%, respectively, all P<0.01), less related to cigarette smoking (45.2% vs 54.2%，P<0.05), but had a higher Killip class of cardiac function on admission (2.0±1.1 vs 1.2±0.5, P<0.01). Compared with those of the survivors, reperfusion therapy within the first 12 hours after symptom onset and the use of beta receptor blockers and nitrates were lower during hospitalization phase in the dead patients (10.1% vs 30.3%，47.0% vs 71.1%，95.2% vs 98.6%, respectively, all P<0.01). The results of logistic regression demonstrated that age, diabetes mellitus, hypertensive disease, Killip classification of cardiac function, reperfusion therapy, and uses of beta receptor blockers and nitrates were significant factors affecting in-hospital death in patients with AMI. CONCLUSION Age, diabetes mellitus, hypertensive disease, Killip classification of cardiac function, reperfusion therapy and uses of beta receptor blockers and nitrates are the significant factors affecting in-hospital death in patients with AMI.

参考文献/References

[1］ Antman EM, Braunwald E. Acute myocardial infarction［M］//Braunwald E, Fauci AS, Kasper DL, et al. Harrison’s principles of internal medicion. New York, NT: McGraw Hill, 2001:1114-1231.

［2］ 中华医学会心血管病学分会，中华心血管病杂志编辑委员会，中国循环杂志编辑委员会. 急性心肌梗死诊断和治疗指南［J］. 中华心血管病杂志， 2001， 29(12)：710-725.

［3］ 蒋世亮，张运，季晓平,等. 我国急性心肌梗死治疗指南对住院患者治疗和预后的影响［J］. 中华心血管病杂志， 2005， 33(9)：779-781.

［4］ 赵玉生，王士雯，吴兴利，等. 年龄及性别对急性心肌梗死患者住院期预后的影响［J］. 中华老年多器官疾病杂志， 2003， 2（3）：196-198.

［5］ Ruiz-Bailén M, Aguayo de Hoyos E, Ramos-Cuadra JA, et al. Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population［J］. Int J Cardiol, 2002, 85(2-3):285-296.

［6］ Kenchaiah S, Pfeffer MA, St John Sutton M, et al. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)［J］. Am J Cardiol, 2004, 94(1):1-8.

［7］ Kodama K, Sakagashira S, Hori M. Prognostic significance of diabetes mellitus in patients with acute myocardial infarction after recanalization［J］. Diabetes Res Clin Pract, 1996, 30（Suppl）:71-75.

［8］ Grudy SM. Primary prevention of coronary heart disease.Integrating risk assessment with intervention［J］. Circulation, 1999, 100（9）:988-998.

［9］ Ishihara M, Kagawa E, Inoue I, et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era［J］. Am J Cardiol, 2007, 99(12):1674-1679.

［10］Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)［J］. Circulation, 2004, 110（9）:e82-e292.

［11］Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial［J］. Lancet, 2001, 357(9266):1385-1390.

［12］ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group［J］. Lancet, 1995, 345（8951）:669-685.

备注/Memo

备注/Memo:
收稿日期：2008-4-22.基金项目：山东省科学技术发展重点项目资助（2002BB1CJA1） 通讯作者：张运，教授，博士，主要从事动脉粥样硬化、心血管重构及血流动力学方面的研究Email:yun-zhang@163.com 作者简介：蒋世亮，副主任医师，博士Email:jsl-telephone@163.com
更新日期/Last Update: 2009-04-16